Table 4.
Clinical factors associated with MetS at bivariate analysis.
| Characteristic | % of MetS | Bivariate analysis | p value |
|---|---|---|---|
| n/N (%) | OR (95% CI) | ||
| HIV status | |||
| Negative | 63 (88.73) | Ref | |
| Positive | 08 (11.27) | 1.00 (0.43–2.32) | 0.998 |
|
| |||
| Mental illness | |||
| BAD | 46 (64.79) | Ref | |
| Schizophrenia | 18 (25.35) | 0.94 (0.50–1.74) | 0.836 |
| Depression | 07 (9.86) | 0.93 (0.37–2.29) | 0.867 |
|
| |||
| Duration of mental illness (years) | |||
| <5 | 24 (33.80) | Ref | |
| 5–10 | 09 (12.68) | 0.72 (0.32–1.66) | 0.446 |
| >10 | 38 (53.52) | 3.11 (1.71–5.68) | <0.001∗ |
|
| |||
| Duration of psychotropic medication (years) | |||
| <5 | 28 (39.44) | Ref | |
| 5–10 | 33 (46.48) | 2.55 (1.40–4.62) | 0.002∗ |
| >10 | 10 (14.08) | 0.75 (0.34–1.64) | 0.465 |
|
| |||
| Antipsychotic | |||
| No | 15 (21.13) | Ref | |
| Yes | 56 (78.87) | 0.78 (0.40–1.52) | 0.468 |
|
| |||
| Antipsychotic class | |||
| Typical | 50 (89.29) | Ref | |
| Atypical | 06 (10.71) | 2.42 (0.82–7.14) | 0.107 |
|
| |||
| Mood stabilizer | |||
| No | 37 (52.11) | Ref | |
| Yes | 34 (47.89) | 0.75 (0.44–1.28) | 0.296 |
|
| |||
| Antidepressant | |||
| No | 53 (74.65) | Ref | |
| Yes | 18 (25.35) | 1.72 (0.91–3.26) | 0.094 |
|
| |||
| Level of physical activity | |||
| <150 min of moderate exercise or 75 min of vigorous/ week | 65 (91.55) | Ref | |
| ≥150 min of moderate exercise or 75 min of vigorous/ week | 06 (8.45) | 0.80 (0.31–2.03) | 0.633 |
Note. BAD: bipolar disorder; MetS: metabolic syndrome; hx: history; OR: odds ratio; CI: confidence interval; Ref: reference category.